Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

56.48
+0.43000.77%
Post-market: 56.480.00000.00%19:49 EDT
Volume:2.40M
Turnover:135.10M
Market Cap:8.40B
PE:-7.38
High:57.00
Open:56.76
Low:55.84
Close:56.05
52wk High:65.00
52wk Low:39.87
Shares:148.81M
Float Shares:136.00M
Volume Ratio:1.72
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6496
EPS(LYR):-5.6333
ROE:-36.51%
ROA:-22.61%
PB:3.05
PE(LYR):-10.03

Loading ...

Vaxcyte EVP, Chief Scientific Officer and COO Jim Wassil Disposes of USD 127,561 in Common Shares

Reuters
·
16 hours ago

Mizuho biotech analysts hold an analyst/industry conference call

TIPRANKS
·
Yesterday

Vaxcyte Price Target Cut to $130.00/Share from $133.00 by B of a Securities

Dow Jones
·
Sep 29

Vaxcyte VAX-31 Positioned to Validate Broad Coverage, BofA Says

MT Newswires Live
·
Sep 28

Vaxcyte, Inc. : Bofa Global Research Cuts Price Objective to $130 from $133

THOMSON REUTERS
·
Sep 28

BofA Securities Adjusts Vaxcyte Price Target to $130 From $133, Maintains Buy Rating

MT Newswires Live
·
Sep 28

Vaxcyte Price Target Maintained with a $110.00/Share by Needham

Dow Jones
·
Sep 25

Vaxcyte EVP, Chief Scientific Officer and COO Jim Wassil Disposes of Common Shares Worth $493,376.94

Reuters
·
Sep 10

Vaxcyte Files Form 3 Disclosing Chief Medical Officer Luis Jodar Stake

Reuters
·
Sep 10

Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data

MT Newswires Live
·
Sep 04

Vaxcyte narrows previously communicated VAX-31 guidance

TIPRANKS
·
Sep 04

Vaxcyte Releases September Investor Presentation

Reuters
·
Sep 04

Vaxcyte Names Luis Jodar as Chief Medical Officer

Reuters
·
Sep 04

Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected Vax-31 Opus-1 Topline Data

THOMSON REUTERS
·
Sep 04

Press Release: Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data

Dow Jones
·
Sep 04

Vaxcyte COO Jim Wassil Disposes of USD 254,221.29 in Common Shares

Reuters
·
Sep 03

Vaxcyte to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 28

Vaxcyte Q2 EPS $(1.97) Beats $(2.22) Estimate

Benzinga Earnings
·
Aug 06

Vaxcyte, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Vaxcyte President, CFO Andrew Guggenhime Disposes of 10,000 Common Shares Worth $538,885

Reuters
·
Aug 06